Inhalant abuse: Difference between revisions

(Text replacement - "Category:Tox" to "Category:Toxicology")
No edit summary
Line 19: Line 19:


==Management==
==Management==
*Supportive care
*Supportive care, cardioversion for dysrhythmias
**Careful use of vasopressors as sympathomimetics may increase risk of dysrhythmias
*If founded down with sudden death with history of recent inhalant abuse → give beta-blocker (propanolol, esmolol)
*If founded down with sudden death with history of recent inhalant abuse → give beta-blocker (propanolol, esmolol)
**Thought to counteract myocardial sensitization
**Thought to counteract myocardial sensitization

Revision as of 14:34, 22 June 2016

Background

  • First described in the 1950s
  • Most common abusant in preteens 11-13yo
  • Most abused: gasoline, solvents like toluene, spray paints, lighter fluid, air fresheners, glue, and electronic cleaners (halogenated hydrocarbons)
  • Includes: "sniffing", "huffing", "bagging", and "dusting"

Clinical Features

  • General: Euphoria, hallucinations
  • Neuro: Impaired motor activity, ataxia, depressed mentation, withdrawal potential
  • Cardiac: Widened QRS, prolonged QT, syncope, arrhythmias
  • Skin: May cause dermal burns
  • "Sudden sniffing death" - thought to be occur with sudden catecholamine surge on a "sensitized" myocardium

Differential Diagnosis

Drugs of abuse

Diagnosis

  • Generally a clinical diagnosis.

Management

  • Supportive care, cardioversion for dysrhythmias
    • Careful use of vasopressors as sympathomimetics may increase risk of dysrhythmias
  • If founded down with sudden death with history of recent inhalant abuse → give beta-blocker (propanolol, esmolol)
    • Thought to counteract myocardial sensitization

Disposition

  • Based on patient's clinical status.

See Also

References